Oligoclonalbands -CSF

Detection of two or more oligoclonal IgG bands in cerebrospinal fluid that are absent from paired serum is generally considered a positive result supportive of multiple sclerosis. A single band is usually not diagnostic. OCBs are an important supportive lab finding but are not definitive alone; diagnosis requires integration of clinical features, MRI, and other investigations.

Oligoclonal bands are discrete IgG bands detected by electrophoresis of cerebrospinal fluid. Their presence—especially when seen in CSF but not serum—indicates intrathecal antibody production and central nervous system immune activation. They strongly support a diagnosis of multiple sclerosis but are not specific: they can also occur with infections, autoimmune or inflammatory CNS disorders. Identical bands in both CSF and serum point to a systemic response rather than local CNS production.

Oligoclonal bands in CSF indicate intrathecal IgG synthesis and are most classically seen in multiple sclerosis and other inflammatory demyelinating disorders (optic neuritis, transverse myelitis). They also occur with CNS infections (viral encephalitis, neurosyphilis, Lyme, HIV), autoimmune CNS diseases (SLE, Sjögren’s, neurosarcoidosis), and paraneoplastic or other chronic inflammatory conditions. Presence supports inflammation but is not disease-specific.

CSF findings supporting multiple sclerosis include oligoclonal IgG bands present only in CSF (not serum), an elevated IgG index or IgG synthesis rate, mild lymphocytic pleocytosis, and normal glucose. Total protein is usually normal or mildly elevated. Detection of myelin basic protein can indicate recent demyelination during relapse. These CSF results are used alongside clinical and MRI findings for diagnosis.

Yes. Oligoclonal bands (OCBs) reflect immune activity in the central nervous system and are common in multiple sclerosis, but they are not specific. OCBs can appear with infections (Lyme, viral encephalitis, neurosyphilis), other inflammatory or autoimmune conditions (neurosarcoidosis, systemic lupus), post‑infectious or paraneoplastic disorders, and rarely in older individuals. MS diagnosis requires clinical and MRI correlation, not OCBs alone.

MRI demonstrating characteristic demyelinating lesions in space (periventricular, juxtacortical, infratentorial, spinal cord) with dissemination in time (new or enhancing versus non‑enhancing lesions), plus cerebrospinal fluid showing CSF‑restricted oligoclonal IgG bands, are the principal test results that confirm multiple sclerosis. Evoked potential abnormalities can further support the diagnosis when correlated with compatible clinical findings.